Skip to main content

Series A Biotechnology Companies

Explore 774 biotechnology startups that raised series a funding. Access verified founder contact information and fundraising data.

Total Companies
774
Total Funding
$613.9M
Avg Funding
$24.6M
Cities
21

Export 774 Series A Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
San Rafael, United States
$37.0M
raised

Koniku merges synthetic biology with silicon to build machines that detect smells.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Waterloo, Canada
$15.6M
raised

Nicoya is a nanotechnology company developing sensor products that will change the world

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

San Jose, United States
$30.0M
raised

Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Courbevoie, France
$34.5M
raised

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Los Angeles, United States

Wake Network's mission is to create a world where natural psilocybin therapies are the primary support for mental health and wellness.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
New York, United States
$37.0M
raised

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$21.0M
raised

Endogena is a biotech company that develops endogenous regenerative medicines to repair and regenerate tissues and organs.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Paris, France
$5.0M
raised

Rarecells Inc. is a healthcare company focused on the development and commercialization of non-invasive Early Cancer Detection tests.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$67.5M
raised

Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

San Diego, United States
$12.0M
raised

Bloom Science is a clinical-stage central nervous system company developing novel therapeutics for patients with neurological disorders.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mclean, United States
$6.0M
raised

KeifeRx is a biotech company focused on the discovery of disease-modifying treatments for neurodegenerative illnesses.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Lausanne, Switzerland
$4.9M
raised

Platform industrial biomass processing technology for nutrition, pharma, cosmetics applications and more

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$15.0M
raised

Limbix is a prescription digital therapeutics platform that provides mental health treatment for young people.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$53.0M
raised

Adendra Therapeutics wants to use new insights into dendritic cell biology to develop a novel type of immunotherapy.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Duisburg, Germany
$98.1M
raised

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Mountain View, United States
$48K
raised

AEENA Dx is developing a saliva-based platform for the detection of cancer and other diseases

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$23.1M
raised

Neutrolis is a candidate-stage company advancing its first-in-class therapies that target Neutrophil Extracellular Traps (NETs).

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Minneapolis, United States
$32.0M
raised

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

Allston, United States
$40.0M
raised

Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.

Dec 2021
Series A

Founder Contacts

41,000+ verified contacts

San Francisco, United States
$15.0M
raised

Fountain Therapeutics is discovering and developing treatments for aging-associated diseases.

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 774 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$25.0M
raised

BAKX Therapeutics is a provider of cancer treatment.

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$2.0M
raised

Glyconics is a diagnostics company, using infrared spectroscopy to analyse samples for markers of disease across a wide range of conditions.

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

New York, United States

TARA Biosystems Harnessing Human Biology + Data to Transform Cardiac Drug Discovery

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

Waltham, United States
$15.0M
raised

Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders.

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

Alameda, United States
$25.0M
raised

Mekonos creates a proprietary cell-engineering platform designed for cell therapies on a chip.

Nov 2021
Series A

Founder Contacts

41,000+ verified contacts

Showing 701 to 725 of 774 companies

Ready to Connect with Series A Biotechnology Startups?

Get verified founder emails, funding details, and company data for 774 series a biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked